| Financial Year |
March 31 2023 |
| Monetary Funds |
736,098,875.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
10,644,207.27 |
| Accounts Receivable |
901,698,778.63 |
| Advances to Suppliers |
24,213,743.23 |
| Other Receivables |
12,150,258.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
750,055,576.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,688,835.41 |
| Other Current Assets |
5,411,799.79 |
| Total Current Assets |
2,847,340,921.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,874,608.75 |
| Long-term Equity Investment |
51,530,906.24 |
| Investment Properties |
10,259,990.75 |
| Fixed Assetes |
1,022,014,490.25 |
| Under-construction Projects |
337,715,841.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
239,094,961.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,938,103.11 |
| Deferred Income Tax Assets |
61,379,731.50 |
| Other Non-Current Assets |
47,082,177.67 |
| Sub-Total of Non-Current Assets |
1,864,670,179.38 |
| Total Assets |
4,712,011,100.90 |
| Short-Term Loans |
414,617,818.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
454,167,061.29 |
| Accounts Payable |
1,119,553,878.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,841,617.74 |
| Taxes Payable |
35,851,042.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,112,315.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
91,803,468.20 |
| Other Current Liabilities |
9,195,422.61 |
| Sub-Total of Current Liabilities |
2,334,586,578.81 |
| Long-term Loans |
113,395,471.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,798,325.24 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
336,439,881.52 |
| Total Liabilities |
2,671,026,460.33 |
| Paid-In Capital(Or Share Stock) |
479,646,926.00 |
| Capital Surplus |
795,019,281.33 |
| Surplus Reserve |
98,411,896.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
589,083,522.33 |
| Minority Stockholder's Interest |
77,048,424.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,963,936,216.06 |
| Owner's Equity（Stockholder's Equity） |
2,040,984,640.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,712,011,100.90 |
